All you need to know about Russia's Sputnik V coronavirus vaccine which is easier to store

In a statement on Tuesday, the vaccine's developers said preliminary data after trials involving thousands of volunteers showed "an efficacy of the vaccine above 95 percent" after a second dose.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2JbLLIR
via IFTTT